ŞEKERCİ, Ç. A. Et Al. 2017. The value of Urinary BDNF levels on assessment of the Botulinum Toxin Type A treatment for neurogenic detrusor overactivity in children with myelodysplasia. EAU 2017 .

ŞEKERCİ, Ç. A., TANIDIR, Y., TOP, T., BAŞOK İŞBİLEN, B., İŞMAN, F., ŞİMŞEK, F., ... AKBAL, C.(2017). The value of Urinary BDNF levels on assessment of the Botulinum Toxin Type A treatment for neurogenic detrusor overactivity in children with myelodysplasia . EAU 2017

ŞEKERCİ, ÇAĞRI Et Al. "The value of Urinary BDNF levels on assessment of the Botulinum Toxin Type A treatment for neurogenic detrusor overactivity in children with myelodysplasia," EAU 2017, 2017

ŞEKERCİ, ÇAĞRI A. Et Al. "The value of Urinary BDNF levels on assessment of the Botulinum Toxin Type A treatment for neurogenic detrusor overactivity in children with myelodysplasia." EAU 2017 , 2017

ŞEKERCİ, Ç. A. Et Al. (2017) . "The value of Urinary BDNF levels on assessment of the Botulinum Toxin Type A treatment for neurogenic detrusor overactivity in children with myelodysplasia." EAU 2017 .

@conferencepaper{conferencepaper, author={ÇAĞRI AKIN ŞEKERCİ Et Al. }, title={The value of Urinary BDNF levels on assessment of the Botulinum Toxin Type A treatment for neurogenic detrusor overactivity in children with myelodysplasia}, congress name={EAU 2017}, city={}, country={}, year={2017}}